Introduction
respiratory tract allergy, allergic rhinoconjunctivitis, Allergic rhinoconjunctivitis, dust mite allergy, Dust mite-induced allergy, allergic reactions
ALLERGIC REACTION, ALLERGIC RHINOCONJUNCTIVITIS
Allergic rhinoconjunctivitis refers to immunoglobulin E (IgE)-mediated transmitter release triggered locally by inhaled allergens in the nasal mucosa, and type I allergic reactions involving multiple cells and immunoactive factors (Dust mite-induced allergy accounts for 85% of all patients with respiratory tract allergy, of which As a conventional immunotherapy, subcutaneous immunotherapy (SCIT) has been confirmed by several meta-analyses and systematic reviews in terms of its sustained benefit and long-term clinical efficacy on allergic rhinoconjunctivitis children (Intra-cervical lymphatic immunotherapy (ICLIT) is a novel immunotherapy for patients with dust mite allergy, and its short-term efficacy and safety have been proved in clinical studies (This prospective randomized controlled study aimed to evaluate the long-term efficacy and safety of ICLIT among children with allergic rhinoconjunctivitis.